Leads investor relations strategy for a clinical-stage biopharmaceutical company, managing investor and analyst relationships, earnings communications, roadshows, presentations, disclosure compliance, market analysis, and IR infrastructure. Also serves as Executive Team Chief of Staff, supporting the CEO and executive committee with meeting coordination, decision follow-up, communications, special projects, and cross-functional initiatives.